Proposals on wastewater treatment will jeopardise patient access to medicines without helping green transition

26 October 2022

PHARMA BOARDROOM – Inflation’s Impact on Medicine Supply: Challenges for the Off-Patent Industry

19 October 2022

Victor Mendonça, chair of the Generic Market Access Committee at […]

MANUFACTURING CHEMIST – EU supply chain regulation: what will it mean for companies attending CPHI?

17 October 2022

Ahead of her session on “Manufacturing Excellence” at CPHI Frankfurt […]

Rapid policy action needed to protect patient access to essential medicines as inflation bites

12 October 2022

PHARMACEUTICAL TECHNOLOGY – Inflation drives pharma manufacturing to focus on sustainability

11 October 2022

Inflation is at an all-time high, opening an opportunity for […]

EU pharmaceutical legislation reform critical to sustain biosimilar medicines competition for the future

6 October 2022

Updated Guide to empower nurses managing patients on biological therapies

3 October 2022

REUTERS – Europe’s generic drugmakers say they may cut output due to energy bills

28 September 2022

The generic drug industry lobby group Medicines for Europe on […]

Open Medicines for Europe letter ahead of the Energy Council – 27 September 2022

27 September 2022

EMA/HMA share definitive EU-wide position on biosimilar medicines interchangeability

19 September 2022